Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Long-term U.S. clinical trial results for orlistat reported in Stockholm

Sep. 3, 1997

Pfizer identifies potent cholesterol absorption inhibitors

Sep. 3, 1997

Crinone launched in the U.S.

Sep. 3, 1997

Mayo Clinic, Wyeth-Ayerst plan fen/phen study

Aug. 29, 1997

Review of fenfluramines points to neurotoxicity

Aug. 29, 1997

FDA wants stronger warning labels for fen/phen

Aug. 29, 1997

First regulatory submission filed for Macritonin

Aug. 28, 1997

CURVES study results point in favor of atorvastatin

Aug. 28, 1997

FDA approves nonsurgical treatment for BPH

Aug. 28, 1997

Roche withdraws NDA for orlistat

Aug. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...